Generics in India
Generics in India
SUMMARY
Generics in India industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in India industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Indian generics market had total revenues of $16.4bn in 2019, representing a compound annual growth rate (CAGR) of 9.7% between 2015 and 2019.
- Market consumption volume increased with a CAGR of 0.4% between 2015 and 2019, to reach a total of 96.6% in 2019.
- India has the third largest market in the Asia-Pacific region and made up 12.7% of regional value in 2019.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in India
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India generics market with five year forecasts by both value and volume
- What was the size of the India generics market by value in 2019?
- What will be the size of the India generics market in 2024?
- What factors are affecting the strength of competition in the India generics market?
- How has the market performed over the last five years?
- How large is India’s generics market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Sun Pharmaceutical Industries Ltd
8.2. Lupin Ltd
8.3. Aurobindo Pharma Ltd
8.4. Cipla Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Sun Pharmaceutical Industries Ltd
8.2. Lupin Ltd
8.3. Aurobindo Pharma Ltd
8.4. Cipla Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: India generics market value: $ billion, 2015-19
Table 2: India generics market volume: % of total pharma, 2015-19
Table 3: India generics market geography segmentation: $ billion, 2019
Table 4: India generics market value forecast: $ billion, 2019-24
Table 5: India generics market volume forecast: % of total pharma, 2019-24
Table 6: Sun Pharmaceutical Industries Ltd: key facts
Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
Table 9: Lupin Ltd: key facts
Table 10: Lupin Ltd: Annual Financial Ratios
Table 11: Lupin Ltd: Key Employees
Table 12: Lupin Ltd: Key Employees Continued
Table 13: Aurobindo Pharma Ltd: key facts
Table 14: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 15: Aurobindo Pharma Ltd: Key Employees
Table 16: Cipla Limited: key facts
Table 17: Cipla Limited: Annual Financial Ratios
Table 18: Cipla Limited: Key Employees
Table 19: India size of population (million), 2015-19
Table 20: India gdp (constant 2005 prices, $ billion), 2015-19
Table 21: India gdp (current prices, $ billion), 2015-19
Table 22: India inflation, 2015-19
Table 23: India consumer price index (absolute), 2015-19
Table 24: India exchange rate, 2015-19
Table 1: India generics market value: $ billion, 2015-19
Table 2: India generics market volume: % of total pharma, 2015-19
Table 3: India generics market geography segmentation: $ billion, 2019
Table 4: India generics market value forecast: $ billion, 2019-24
Table 5: India generics market volume forecast: % of total pharma, 2019-24
Table 6: Sun Pharmaceutical Industries Ltd: key facts
Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
Table 9: Lupin Ltd: key facts
Table 10: Lupin Ltd: Annual Financial Ratios
Table 11: Lupin Ltd: Key Employees
Table 12: Lupin Ltd: Key Employees Continued
Table 13: Aurobindo Pharma Ltd: key facts
Table 14: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 15: Aurobindo Pharma Ltd: Key Employees
Table 16: Cipla Limited: key facts
Table 17: Cipla Limited: Annual Financial Ratios
Table 18: Cipla Limited: Key Employees
Table 19: India size of population (million), 2015-19
Table 20: India gdp (constant 2005 prices, $ billion), 2015-19
Table 21: India gdp (current prices, $ billion), 2015-19
Table 22: India inflation, 2015-19
Table 23: India consumer price index (absolute), 2015-19
Table 24: India exchange rate, 2015-19
LIST OF FIGURES
Figure 1: India generics market value: $ billion, 2015-19
Figure 2: India generics market volume: % of total pharma, 2015-19
Figure 3: India generics market geography segmentation: % share, by value, 2019
Figure 4: India generics market value forecast: $ billion, 2019-24
Figure 5: India generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in India, 2019
Figure 7: Drivers of buyer power in the generics market in India, 2019
Figure 8: Drivers of supplier power in the generics market in India, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2019
Figure 11: Drivers of degree of rivalry in the generics market in India, 2019
Figure 1: India generics market value: $ billion, 2015-19
Figure 2: India generics market volume: % of total pharma, 2015-19
Figure 3: India generics market geography segmentation: % share, by value, 2019
Figure 4: India generics market value forecast: $ billion, 2019-24
Figure 5: India generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in India, 2019
Figure 7: Drivers of buyer power in the generics market in India, 2019
Figure 8: Drivers of supplier power in the generics market in India, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2019
Figure 11: Drivers of degree of rivalry in the generics market in India, 2019
